Led by scientific experts, our team at DUHS possesses a profound understanding of the complexities inherent in nephrology studies, spanning both rare and common indications. We are intimately familiar with the perspectives of patients, clinicians, sites including dialysis centre, and other key stakeholders. This insight allows us to tailor study designs and develop effective strategies that ensure timely recruitment and successful study completion.

In the rapidly evolving field of nephrology drug development, competition for patients with rare kidney diseases is intense. Our extensive experience and deep knowledge of kidney disease enable us to navigate these challenges adeptly. We have a proven track record in designing, recruiting for, and completing studies across a wide spectrum of rare diseases within nephrology. Learn more about National Institute of Solid Organ & Tissue Transplantation.